Login to Your Account



After Recommendation, First Biosimilar Approval Imminent

By Nuala Moran


Wednesday, February 1, 2006
LONDON - Europe has opened the floodgates to generic biopharmaceuticals, agreeing that the human growth hormone Omnitrope, manufactured by Sandoz GmbH, is equivalent in quality, safety and efficacy to the registered originator product. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription